Corient Private Wealth’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.85M Sell
17,038
-342
-2% -$121K 0.01% 778
2026
Q1
$5.53M Buy
17,380
+13,815
+388% +$4.12M 0.01% 812
2025
Q4
$922K Buy
3,565
+2,561
+255% +$583K ﹤0.01% 1552
2025
Q3
$228K Buy
+1,004
New +$206K ﹤0.01% 2292
2024
Q1
Sell
-1,488
Closed -$271K 2334
2023
Q4
$271K Buy
+1,488
New +$258K ﹤0.01% 1913

Other funds holding MSGS

Corient Private Wealth's MSGS Position: Q2 2026 in Review

Corient Private Wealth reduced its Madison Square Garden (MSGS) stake by 2% in Q2 2026, selling an estimated $121K and leaving 17,038 shares worth $6.85M. The position accounts for 0.01% of the portfolio, ranked #778.

Corient Private Wealth first reported a position in MSGS in Q4 2023 and has held it in 5 quarters since. 469 funds tracked by Wall St. Rank hold MSGS as of Q2 2026.

  • Corient Private Wealth held 17,038 shares of Madison Square Garden worth $6.85M as of Q2 2026.
  • Corient Private Wealth sold 342 Madison Square Garden shares in Q2 2026, an estimated $121K.
  • Madison Square Garden made up 0.01% of Corient Private Wealth's portfolio in Q2 2026, its #778 holding.
  • Corient Private Wealth first reported a position in Madison Square Garden in Q4 2023 and has held it in 5 quarters since.
  • 469 funds tracked by Wall St. Rank held Madison Square Garden as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.